Clinical Trials Browser

INDUSTRY × Lymphoma, T-Cell, Peripheral × belinostat × Clear all

NCT06561048 2026-04-08

Soquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Specified, Follicular Helper T-cell Lymphomas, or Systemic Anaplastic Large-cell Lymphoma

Phase 3 Recruiting

Immunoblastic Lymphadenopathy, Lymphoma, T-Cell, Lymphoma, T-Cell, Peripheral, Lymphoma, Large-Cell, Anaplastic

NCT06072131 2025-10-23

CRESCENDO

Phase 3 Recruiting

Lymphoma, T-Cell, Peripheral

NCT00865969 2021-10-29

PTCL

Phase 2 Completed

129 enrolled 12 charts

Lymphoma, T-Cell, Peripheral

NCT01839097 2020-01-03

Phase 1 Dose Finding Study of Belinostat for Treatment of Patients With Peripheral T-cell Lymphoma (PTCL)

Phase 1 Completed

Lymphoma, T-Cell, Peripheral

NCT00274651 2015-07-28

PXD101-CLN-6

Phase 2 Terminated

53 enrolled 12 charts

DermatologicLymphoid

Lymphoma, Lymphoma, Non-Hodgkin, Lymphoma, T-Cell, Cutaneous, Lymphoma, T-Cell, Peripheral